Patient Selection Articles & Analysis: This-Month

1 articles found

Abandoned oncology drugs -Identifying new indications using active machine learning and a biobank of patient derived dissociated tumor cells (DTCs)

Marrying this approach with the ability to deploy a biomarker-based strategy for selecting targeted patient cohorts can significantly derisk the clinical trial process ...

Aug. 12, 2025

ByPredictive Oncology Inc.

Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you